Shari Bossuyt from the Canyon-Sram team, has been suspended from racing testing positive for Letrozole, a prohibited substance. Letrozole is usually prescribed for the treatment of estrogen-sensitive cancer in post-menopausal women. Its potential doping effect is comparable to testosterone, which is why it is included on WADA’s list of banned substances. Bossuyt is the current madison world champion.
CANYON//SRAM Racing statement concerning Shari Bossuyt. pic.twitter.com/DggZD0LZPB
— CANYON//SRAM Racing & CANYON//SRAM Generation (@WMNcycling) June 4, 2023
In 2022, ‘cross rider Toon Aerts also tested positive for Letrozole in late 2022. Despite denying any wrongdoing and refusing to accept a two-year suspension, Aerts has been unable to provide evidence supporting his claim that his case was a result of contamination.
Canyon/Sram posted a statement about the A and B sample positive on Sunday on Twitter.
“Canyon/SRAM Racing has a zero-tolerance stance towards any use of prohibited substances in accordance with WADA Anti-Doping Regulations. Adherence to the anti-doping rules is therefore part of all contracts between all riders and Canyon/SRAM Racing,” the statement read. “In accordance with its own anti-doping rules, the team has made Shari provisionally non-active for Canyon/SRAM Racing. The team is now waiting for the decision of The French Anti-Doping Agency before taking any further action.”
Bossuyt and her manager are scheduled to hold a press conference in Belgium on Monday. T
Click Here to Read the Full Original Article at Canadian Cycling Magazine…